Article info

Download PDFPDF

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

Authors

  1. Correspondence to Dr Oliver Hendricks; hendricks{at}dadlnet.dk
View Full Text

Citation

Hendricks O, Andersen TE, Christiansen AA, et al
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study

Publication history

  • Received November 26, 2018
  • Revised April 18, 2019
  • Accepted April 18, 2019
  • First published June 4, 2019.
Online issue publication 
June 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.